Evaluating S100B as a serum biomarker for central neurosarcoidosis
Authors:
- 1 February 2020
- journal article
- research article
- Published by Elsevier in Respiratory Medicine
- Vol. 162, 105855
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- Biomarkers in sarcoidosisExpert Review of Clinical Immunology, 2016
- Total tau and S100b proteins in different types of multiple sclerosis and during immunosuppressive treatment with mitoxantroneActa Neurologica Scandinavica, 2011
- Biological and methodological features of the measurement of S100B, a putative marker of brain injuryClinical Biochemistry, 2008
- Treatment response in relation to inflammatory and axonal surrogate marker in multiple sclerosisMultiple Sclerosis Journal, 2004
- The PHQ-9Journal of General Internal Medicine, 2001
- Predictive value of S-100β and neuron-specific enolase serum levels for adverse neurologic outcome after cardiac surgeryThe Journal of Thoracic and Cardiovascular Surgery, 2000